Back

Lethal giant larvae gene family (Llgl1 and Llgl2) functions as a tumor suppressor in mouse skin epidermis

Bii, V. M.; Rudoy, D.; Klezovitch, O.; Vasioukhin, V.

2023-03-08 cancer biology
10.1101/2023.03.06.531408 bioRxiv
Show abstract

Loss of cell polarity and tissue disorganization occurs in majority of epithelial cancers. Studies in simple model organisms identified molecular mechanisms responsible for the establishment and maintenance of cellular polarity, which play a pivotal role in establishing proper tissue architecture. The exact role of these cell polarity pathways in mammalian cancer is not completely understood. Here we analyzed the mammalian orthologs of drosophila apical-basal polarity gene lethal giant larvae (lgl), which regulates asymmetric stem cell division and functions as a tumor suppressor in flies. There are two mammalian orthologs of lgl (Llgl1 and Llgl2). To determine the role of the entire lgl signaling pathway in mammals we generated mice with ablation of both Llgl1 and Llgl2 in skin epidermis using K14-Cre (Llgl1/2-/- cKO mice). Surprisingly, we found that ablation of Llgl1/2 genes does not impact epidermal polarity in adult mice. However, old Llgl1/2 cKO mice present with focal skin lesions which are missing epidermal layer and ripe with inflammation. To determine the role of lgl signaling pathway in cancer we generated Trp53-/-/Llgl1/2-/- cKO and Trp53-/+/Llgl1/2-/- cKO mice. Loss of Llgl1/2 promoted squamous cell carcinoma (SCC) development in Trp53-/- cKO and caused SCC in Trp53-/+ cKO mice, while no cancer was observed in Trp53-/+ cKO controls. Mechanistically, we show that ablation of Llgl1/2 causes activation of aPKC and upregulation of NF-kB signaling pathway, which may be necessary for SCC in Trp53-/+/Llgl1/2-/- cKO mice. We conclude that Lgl signaling pathway functions as a tumor suppressor in mammalian skin epidermis.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

1
Journal of Investigative Dermatology
49 papers in training set
Top 0.1%
39.0%
2
Disease Models & Mechanisms
119 papers in training set
Top 0.2%
7.2%
3
Experimental Dermatology
10 papers in training set
Top 0.1%
5.5%
50% of probability mass above
4
eLife
5828 papers in training set
Top 27%
4.3%
5
Pigment Cell & Melanoma Research
11 papers in training set
Top 0.1%
4.3%
6
JID Innovations
11 papers in training set
Top 0.1%
4.0%
7
PLOS Genetics
862 papers in training set
Top 5%
2.4%
8
Biology Open
156 papers in training set
Top 1%
2.1%
9
Scientific Reports
3612 papers in training set
Top 51%
1.9%
10
PLOS ONE
5266 papers in training set
Top 49%
1.7%
11
Cancers
213 papers in training set
Top 3%
1.7%
12
Life Science Alliance
285 papers in training set
Top 4%
1.5%
13
EMBO Reports
263 papers in training set
Top 4%
1.5%
14
iScience
1154 papers in training set
Top 20%
1.5%
15
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 35%
1.1%
16
Journal of Cell Science
393 papers in training set
Top 4%
1.0%
17
Frontiers in Cell and Developmental Biology
233 papers in training set
Top 4%
1.0%
18
Cell Death Discovery
58 papers in training set
Top 2%
0.8%
19
Cell Death & Differentiation
48 papers in training set
Top 1%
0.8%
20
Molecular and Cellular Biology
47 papers in training set
Top 0.9%
0.8%
21
Molecular Biology of the Cell
311 papers in training set
Top 3%
0.8%
22
Cancer Research
130 papers in training set
Top 3%
0.6%
23
The FASEB Journal
194 papers in training set
Top 7%
0.6%
24
Cell Reports
1498 papers in training set
Top 30%
0.6%